Tags

Type your tag names separated by a space and hit enter

Acute generalized exanthematous pustulosis induced by terbinafine.
Eur J Dermatol. 2003 May-Jun; 13(3):313-4.EJ

Abstract

Terbinafine is an allylamine fungicidal agent that is widely used for the treatment of onychomycoses and other fungal infections. Adverse effects may occur in more than 10% of patients receiving oral terbinafine, with cutaneous reactions in 2.7%. We describe the development of acute generalized exanthematous pustulosis in a 36-year-old woman who took oral terbinafine.

Authors+Show Affiliations

Department of Dermatology, Hospital de Son Llàtzer, Carretera de Manacor, Km. 4, Son Ferriol, 07198 Palma de Mallorca, Spain. rtaberne@hsll.esNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Case Reports
Journal Article
Review

Language

eng

PubMed ID

12805000

Citation

Taberner, Rosa, et al. "Acute Generalized Exanthematous Pustulosis Induced By Terbinafine." European Journal of Dermatology : EJD, vol. 13, no. 3, 2003, pp. 313-4.
Taberner R, Puig L, Gilaberte M, et al. Acute generalized exanthematous pustulosis induced by terbinafine. Eur J Dermatol. 2003;13(3):313-4.
Taberner, R., Puig, L., Gilaberte, M., & Alomar, A. (2003). Acute generalized exanthematous pustulosis induced by terbinafine. European Journal of Dermatology : EJD, 13(3), 313-4.
Taberner R, et al. Acute Generalized Exanthematous Pustulosis Induced By Terbinafine. Eur J Dermatol. 2003 May-Jun;13(3):313-4. PubMed PMID: 12805000.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Acute generalized exanthematous pustulosis induced by terbinafine. AU - Taberner,Rosa, AU - Puig,Lluis, AU - Gilaberte,Montserrat, AU - Alomar,Agustín, PY - 2003/6/14/pubmed PY - 2003/10/1/medline PY - 2003/6/14/entrez SP - 313 EP - 4 JF - European journal of dermatology : EJD JO - Eur J Dermatol VL - 13 IS - 3 N2 - Terbinafine is an allylamine fungicidal agent that is widely used for the treatment of onychomycoses and other fungal infections. Adverse effects may occur in more than 10% of patients receiving oral terbinafine, with cutaneous reactions in 2.7%. We describe the development of acute generalized exanthematous pustulosis in a 36-year-old woman who took oral terbinafine. SN - 1167-1122 UR - https://www.unboundmedicine.com/medline/citation/12805000/Acute_generalized_exanthematous_pustulosis_induced_by_terbinafine_ DB - PRIME DP - Unbound Medicine ER -